FDA Says Mylan ' s EpiPen Is in Shortage FDA Says Mylan ' s EpiPen Is in Shortage

U.S. regulators said on Wednesday that Mylan NV ' s EpiPen products are in shortage, due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy treatment.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news